Tina DeNofrio, RN, BSN, OCN
Dana-Farber Cancer Institute
Harvard Medical School
Boston, MA
Harvard Medical School
Boston, MA
Authored Items
December 17, 2021 | November 2021 Vol 12, No 11 | Research/Quality/Performance Improvement
Prostate cancer (PCa) patients treated with injectable androgen deprivation therapy (ADT) are particularly vulnerable during a pandemic because they may not be able to self-administer treatment and may be required to visit a clinic/hospital for injections.
Last modified: December 17, 2021
